Articolul precedent |
Articolul urmator |
58 0 |
SM ISO690:2012 GALESCU, Andrei, SAJIN, Octavian, SPÎNU, Constantin, ISAC, Maria, BLAJ, Valentina, IZIUMOV, Nina, SPÎNU, Igor, IVANOV (LITOVCENCO), Mihaela, VALISIEV, Vladislav, CEBAN, Emil. Serologic status prevalence of viral hepatitis a, b, c, and e markers at urology healthcare workers. In: New horizons in urology: The 8th congress on urology, dialysis and kidney transplant from Republic of Moldova with international participation, 7-9 iunie 2023, Chişinău. Chişinău: Taicom (Ridgeone Group), 2023, p. 387. ISSN 2558-815X. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
New horizons in urology 2023 | ||||||
Conferința "New horizons in urology" Chişinău, Moldova, 7-9 iunie 2023 | ||||||
|
||||||
Pag. 387-387 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Objectives. To determine the seroprevalence level of viral hepatitis markers A, B, C, and E among urological healthcare from department of Republican Clinical Hospital. Methods. A crosssectional descriptive epidemiological study was conducted. Blood samples were collected from medical workers and examined using the enzymelinked immunosorbent assay (ELISA) method for markers of viral hepatitis A (anti-HAV and anti-HAV IgM), viral hepatitis B (AgHBs, antiHBcor, anti-HBs), viral hepatitis C (anti-HCV), and viral hepatitis E (anti-HEV IgG and antiHEV IgM). A total of 49 medical workers were examined, and 392 laboratory investigations were performed. Results. The following seroprevalence levels of viral markers were identified among urology healthcare: AgHBs–2.0±2.0%; antiHBcor–38.8±7.0%; anti-HBs–51.0±7.1%; antiHCV– 4.1±2.8%; anti-HAV–100%; anti-HAV IgM–0%; anti-HEV IgG–12.2±4.7%; anti-HEV IgM– 12.2±4.7%. The most affected groups were female individuals, medical assistants or auxiliary personnel, and with a work experience of ≥30 years. Conclusions. The results indicate that medical workers in the field of urology can be considered a high-risk group for infection with hepatitis B, C, and E viruses. |
||||||
|